New Data Recommend Continuous Monitoring of Lymphedema for Breast Cancer

In case you missed last month’s publication in Annals of Surgical Oncology, Cancer Network has highlighted key findings from the PREVENT study. The study emphasizes the crucial need for continuous lymphedema monitoring for at least three years after breast cancer therapy.